Skip to main content

$15 Million Chopped From A Pelvic Mesh Verdict

$15 Million Chopped From A Pelvic Mesh Verdict

$15 Million Chopped From A Pelvic Mesh Verdict

Introduction

A $35 million verdict linked to Johnson & Johnson's Ethicon pelvic mesh injury lawsuit by a plaintiff was altered by an Indiana federal Judge. The Jury announced that the woman must accept a $15 million reduction, to avoid a new trial on punitive damages.

The plaintiff got the Prolift transvaginal mesh implanted in 2009 to treat pelvic organ prolapse. She developed severe pelvic pain and filed a lawsuit against the mesh manufacturer in 2012, alleging that the defectively designed mesh caused her irreversible injuries. The lawsuit blames Ethicon for hiding critical information regarding the health risks associated with their device and intentionally misinformed the public and healthcare providers.

Many women across the U.S. who implanted transvaginal mesh for treating pelvic organ prolapse (POP) and stress urinary incontinence (SUI) blame the device makers for inadequate warning. Ethicon Pelvic Mesh lawsuits are consolidated as a part of a multidistrict litigation (MDL No. 2327; In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation U.S. District Judge Joseph R. Goodwin U.S. District Court for the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!